MLM Participates in Important Non-Inverventional Hidradenitis Suppurativa (HS) Study
MLM Medical Labs Supports Leading Biotech Company in a Non-Interventional Hidradenitis Suppurativa (HS) Study MLM Medical Labs – Minneapolis recently partnered with a leading biotech company on the CSL324 study of a novel, fully human anti-G-CSF receptor (G-CSFR) monoclonal antibody in the treatment of hidradenitis suppurativa (HS). CSL324 is being investigated as a potential treatment in …
MLM Participates in Important Non-Inverventional Hidradenitis Suppurativa (HS) Study Read More »